ロード中...

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

AIM: High dose melphalan (HDM) and autologous stem cell transplantation (ASCT) retains a central role in the treatment of myeloma. The aim of this study was to determine whether HDM exposure (area under the concentration vs. time curve, AUC), is significantly associated with transplant outcomes. MET...

詳細記述

保存先:
書誌詳細
出版年:Br J Clin Pharmacol
主要な著者: Nath, Christa E., Trotman, Judith, Tiley, Campbell, Presgrave, Peter, Joshua, Douglas, Kerridge, Ian, Kwan, Yiu Lam, Gurney, Howard, McLachlan, Andrew J., Earl, John W., Nivison‐Smith, Ian, Zeng, Lihua, Shaw, Peter J.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4917807/
https://ncbi.nlm.nih.gov/pubmed/26879446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12906
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!